How is the DiaMedica Therapeutics Inc today?

The DiaMedica Therapeutics Inc today is trading in the down by -1.20% at 4.12.

How has DiaMedica Therapeutics Inc performed historically?

The DiaMedica Therapeutics Inc is currently trading down -1.20% on an intraday basis in the past week the index rose 1.48%. The index has been down -36.91% in the past quarter and rose 42.07% in the past year. You can view this in the overview section.

What is DiaMedica Therapeutics Inc Annual Net Profit?

DiaMedica Therapeutics Inc Annual Net Profit fell 26.12% in the last year to $24.44 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is DiaMedica Therapeutics Inc Price to Earning Ratio?

DiaMedica Therapeutics Inc Price to Earning Ratio is -6.54, which is negative.

What is DiaMedica Therapeutics Inc Stock Price?

DiaMedica Therapeutics Inc Stock Price rose 42.07% and outperformed its sector by 15.53% in the past year.

What is DiaMedica Therapeutics Inc Quarterly Net profit?

DiaMedica Therapeutics Inc Quarterly Net profit fell 49.62% YoY to $7.71 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is DiaMedica Therapeutics Inc Debt to Equity Ratio?

DiaMedica Therapeutics Inc Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is DiaMedica Therapeutics Inc Return on Equity(ROE)?

DiaMedica Therapeutics Inc Return on Equity(ROE) for the last financial year was -53.27%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is DiaMedica Therapeutics Inc Mutual Fund Holding?

DiaMedica Therapeutics Inc Mutual Fund Holding decreased by 0.02% in the last quarter to 7.35.

What is DiaMedica Therapeutics Inc Promoter Share Holding?

DiaMedica Therapeutics Inc Promoter Share Holding decreased by 1.92% in the most recent quarter to 8.24%.

What is DiaMedica Therapeutics Inc Institutional Holding?

DiaMedica Therapeutics Inc Institutional Holding increased by 1.14% in the last quarter to 17.3.

DiaMedica Therapeutics Inc XNAS: DMAC

DiaMedica Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: DiaMedica Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: DiaMedica Therapeutics Inc
Rating: 1.25175
Author: Trendlyne DVM scores

about

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing treatment for ischemic diseases with two main clinical programs focused on acute ischemic stroke (AIS) and preeclampsia (PE). Its main prod...

4.12 -0.05 (-1.20%)

39.59% Fall from 52W High

166.0K XNAS Volume

XNAS 03 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for DiaMedica Therapeutics Inc is on 04 Jun 2025 for the purpose of Jefferies Global Healthcare Conference 2025 See details

Not Eligible

Expensive Valuation

0.0 / 100

Technically Neutral

50.1 / 100

No estimates available

DiaMedica Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

DiaMedica Therapeutics Inc Live Share Price Today, Share Analysis and Chart

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing treatment for ischemic diseases with two main clinical programs focused on acute ischemic stroke (AIS) and preeclampsia (PE). Its main prod...

39.59% Fall from 52W High

SWOT Analysis

DiaMedica Therapeutics Inc Live Price Chart

DiaMedica Therapeutics Inc FAQ

How is DiaMedica Therapeutics Inc today?

DiaMedica Therapeutics Inc today is trading in the red, and is down by -1.20% at 4.12.

How has DiaMedica Therapeutics Inc performed historically?

DiaMedica Therapeutics Inc is currently trading down -1.20% on an intraday basis. In the past week the stock rose 1.48%. stock has been down -36.91% in the past quarter and rose 42.07% in the past year. You can view this in the overview section.